“With these new drugs now available in clinical practice, we expect HER2+/HER2-low BC patients with BMs to live longer and to live better.” Credit:...
Only time and data will tell whether the CDC-recommended reformulated shots can stand their ground against the ever-changing SARS-CoV-2 variants.
BIRMINGHAM, Ala. – In the summer of 2018, graduate student Hunter Dean from the Medical Scientist Training Program came to Yuhua Song, Ph.D., with a...
A standard chemotherapy drug injures surrounding non-cancer cells, which can then awakens dormant cancer cells and promotes cancer growth, according to...
Arialys Therapeutics announced Tuesday that it tied the bow on a $58 million seed round to develop treatments specifically for brain disorders caused by...
Conventional crop breeding is not time-efficient for creating inbred lines with desired genetic traits owing to the diploid nature of plants, wherein they...
Photos, b-roll and video available for download in electronic media kit: https://t.ly/RRu-V. (Credit: City of Hope) Credit: Panda Restaurant Group Inc....
Researchers still don’t know how well BA.2.86 will evade immunity or whether it will cause more severe disease than its predecessors.
Sen. Bernie Sanders (I-VT), chairman of the health committee, said late Friday that he would lift his hold on President Biden’s nominee to run the National...
A Deeper Dive Into The Role Of Spike Protein In Myocarditis And Blood Clotting After COVID-19 Vaccination Authored by Allison Kruig, MPH and...
“While vaccination has been successful for the general population, it is crucial not to overlook the needs of immunocompromised individuals.” Credit:...
- by New Deal democratAt the beginning of this year, I indicated that I anticipated only writing about Covid if something significant was happening....
COVID-19 mRNA Vaccines Reduce Immune Response To Other Infections, Potential Concern Of Immune Deficiency Authored by Marina Zhang via The...
COVID has spread many times from humans to white-tailed deer and back again.
Engineers at the University of Cincinnati have developed a new device that can warn consumers about early risks of tooth decay from diseases such as gingivitis...
Seagen, whose suite of antibody-drug conjugates enticed Pfizer to a $43 billion buyout, is looking to put a twist on the idea. The Seattle-based drugmaker...
MIAMI, FLORIDA (Sept. 6, 2023) – A new study from researchers with Sylvester Comprehensive Cancer Center at the University of Miami Miller School of...
As Moderna awaits an FDA decision to kick-start its fall Covid vaccination campaign, the biotech is continuing to beef up its data package. Moderna reported...
Equities continue to shrug off anything the world throws at them as we sit on the precipice of huge technological breakthroughs in energy, biotech, AI,...
Star Therapeutics, which created two antibody-focused biotech startups with more in the works, has now reeled in a $90 million Series C. The round, disclosed...
Pixelgen Technologies describes a DNA-based visualization technology for mapping cell surface proteins and their spatial interrelationships. The post Single-Cell...
Besides identifying and quantifying contaminants, new assays and algorithms are contextualizing them across developmental stages and patient populations. The...
From Cambridge, U.K., to Cambridge, MA, and from creating better cytokines to aiding gene therapy, the development of new amino acids is likely to open...
Bavarian Nordic is abandoning its Covid-19 booster vaccine after Phase III results — even though it did hit the primary endpoint of the study — because...
OAK BROOK, Ill. (August 31, 2023) – A new article published in RadioGraphics, a journal of the Radiological Society of North America (RSNA), examines...
Are We Facing Lockdowns 2.0? Authored by Jeffrey Tucker via The Brownstone Institute, National Public Radio was in a frenzy this morning...
The research, led jointly by the University of Seville-IBiS and Karolinska Institutet, helps to understand how neural systems with decisive functions for...
Ishikawa, Japan — Targeting malignant tumors with high precision is challenging for biomedical researchers. However, this scenario is likely to witness...
Danaher will buy Abcam, a research tools supplier relied upon by many biopharmas, for an enterprise value of about $5.7 billion, the companies announced...
Nearly 100,000 US children under age 5 are hospitalized each year for an RSV infection.